The Schubert-Martin Inflammatory Bowel Disease (IBD) Center at @CincyChildrens helps children with Crohn’s disease, ulcerative colitis and very early-onset IBD
We have an exciting opportunity for fellows interested in an Advanced Pediatric IBD Fellowship @CincyKidsIBD with a start date of *July 1st 2022!* More info ⬇️:
https://t.co/Olf6TCX2Ns
Population pharmacokinetic study identifies novel predictors (blood & stool) of vedolizumab clearance in children and young adults. Data suggests that children may require more frequent vedolizumab infusions to achieve therapeutic drug targets. https://t.co/8vjuXjlRkR
Strong paper lead by @ChildrensMercy IBD specialist and former @CincyKidsIBD co-fellow, Katy Clarkston. Evaluating targeted gene expression to predict clinical outcomes in Tx naive UC patients - @DrRosenIBD@CincyChildrens
#MRI T1 relaxation... looks like estimates maybe useful beyond the heart and liver!
@Abdominal_Rad@CincyKidsRad@CincyKidsIBD@SAR_CrohnsDFP
Bowel wall MRI T1 relaxation estimates for assessment of intestinal inflammation in pediatric Crohn's disease. https://t.co/TSu1fnA4Nh
MRI-based ileal motility changes over time when starting biologics in Pediatric Crohn. A potential novel pharmacodynamic biomarker for disease activity? Congrats @therealjonadill@CincyKidsRad!
#CDDW2022@CanGastroAssn Dr. Ted Denson giving a tour de force Hinda Kopelman Memorial Lecture of his program’s exciting IBD research- from patients to organoid models to novel therapeutics
Please RT - there is an exciting open position in the Kottyan lab (combined lab with Dr. Matt Weirauch) for someone who has earned a PhD with functional genomic experience. We are hiring into a "Research Associate" rather than "postdoc" position to give us salary flexibility.